Taken together, our findings revealed that SLC16A1-AS1 was a tumor suppressor and inhibited the tumorigenesis and highly aggressive behaviors of BC cells via sponging miR-552-5p to activate WIF1 both in vitro and in vivo. Here, SLC16A1 is linked to breast cancer.